Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Mesothelioma × MAC321 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Rectal Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 14 Pemetrexed 12 Cisplatin 10 Nivolumab 8 Carboplatin 7 Ipilimumab 6 tazemetostat 3 anetumab ravtansine 3 fludarabine 2 budigalimab 2 belinostat 2 Vinorelbine 2 Paclitaxel 2 Docetaxel 2 Cyclophosphamide 2 venetoclax 1 vandetanib 1 trametinib 1 tocilizumab 1 tislelizumab 1 spartalizumab 1 rovalpituzumab tesirine 1 ribociclib 1 rebastinib 1 osimertinib 1 obinutuzumab 1 nintedanib 1 naptumomab estafenatox 1 milademetan 1 epacadostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00685204 2008-05-28

TL139

Taxolog Inc.

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡